| Objective: Objective To observe the clinical efficacy and safety of Shenqi Danting Decoction in the treatment of coronary heart disease with heart failure due to Qi deficiency,blood stasis and water stagnation,so as to provide more new choices for the prevention and treatment of coronary heart disease and heart failure with traditional Chinese medicine.Methods: The 62 test subjects were randomly divided into a test group and a control group,with 31 in each group.Both groups were treated with conventional Western medicine,and the experimental group was treated with Shenqi Danting Decoction.The trial period was 1 month.Collect the relevant data of each test subject before and after treatment,including heart function,TCM syndrome,N-terminal pro-B-type natriuretic peptide(NT-pro BNP),left ventricular ejection fraction(LVEF),etc.,and analyze the parameters by statistical software to determine The clinical efficacy and safety of Shenqi Danting Decoction.Results: A total of 60 subjects were included in the study,30 in each group.After statistical analysis,the LVEF values of the two groups of test subjects increased compared with the previous(P<0.05),and the NT-pro BNP value,TCM syndrome scores,and the Minnesota Quality of Life Scale scores were all decreased compared with the previous(P<0.05).The efficacy of the test group was better than the control group(P<0.05).During the test period,1 of the two groups of test subjects had mild dry cough symptoms after starting the medication,and the rest of the patients had no adverse reactions.Conclusion: The effect of Shenqi Danting decoction combined with routine western medicine in the treatment of coronary heart disease with heart failure due to Qi deficiency,blood stasis and water stagnation is better than that of routine western medicine alone,and has good safety. |